|
16th February 2008
Toroed, Norway
AME Bioscience Nordic and Director of Sales.
AME Bioscience A/S today announced a new Division, AME Bioscience Nordic which will focus on delivering novel life science application systems to the region.
The company will introduce to Norway, Sweden, Denmark, Finland and Iceland instrumentation, kits and service support that will enable researchers and clinicians to perform more analysis of DNA and proteins in less time and for less cost.
To manage and develop this new Division Mats Bergstroem as Director of Sales Nordic has agreed to accept this challenging position. Mats has previously held senior Nordic, European and Wordwide Sales and Marketing roles in, Pharmacia Biotech (now GE), Applied Biosystems, Pyrosequencing (now Biotage) and Gyros. His knowledge of the Nordic market and his experience of building applications based businesses will be invaluable to the growth and development of AME Bioscience Norden.
About AME Bioscience
AME Bioscience (established 2002) is a privately owned life science company with offices and employees in Norway, Sweden, UK and Germany and an affiliate in the USA. The company is dedicated to develop sell and support products that simplify the methods used for DNA & Protein research and diagnostics. The people behind AME Bioscience have their industrial experience from Applied Biosystems, Pyrosequencing, Gyros and Philips Medical.The AME Bioscience team has previously had success with developing and supporting international markets for automated nucleic acid analysis products for research, clinical and diagnostic laboratories.
Further details are available by contacting AME Bioscience
Nordic: Tel. +47 33 610 718
UK : Tel +44 7720 400 161
www.amebioscience.com
|
|
